Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirasemtiv in generalized myasthenia gravis
NCT01268280Phase 2Terminated
- Sponsor
- Cytokinetics
- Start
- Dec 2010
- Primary completion
- Oct 2012
- Countries
- 1
01
Overview
A Phase 2 trial of tirasemtiv in myasthenia gravis (MG), sponsored by Cytokinetics. Started Dec 2010; status: terminated.
02
Drugs
tirasemtiv
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT01268280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01268280.